29 related articles for article (PubMed ID: 12480545)
1. Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.
Kazi AA; Molitoris KH; Koos RD
Biol Reprod; 2009 Aug; 81(2):378-87. PubMed ID: 19420388
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen receptor-independent actions of oestrogen in cancer.
Gopinath P; Oviya RP; Gopisetty G
Mol Biol Rep; 2023 Nov; 50(11):9497-9509. PubMed ID: 37731028
[TBL] [Abstract][Full Text] [Related]
3. Kinetic Study of 17α-Estradiol Mechanism during Rat Sperm Capacitation.
Bosakova T; Tockstein A; Bosakova Z; Komrskova K
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807338
[TBL] [Abstract][Full Text] [Related]
4. Adenylate Kinase 4 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an m
Liu X; Gonzalez G; Dai X; Miao W; Yuan J; Huang M; Bade D; Li L; Sun Y; Wang Y
Mol Ther; 2020 Dec; 28(12):2593-2604. PubMed ID: 32956623
[TBL] [Abstract][Full Text] [Related]
5. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas.
Liu D; Li J; Li N; Lu M; Wen S; Zhan X
EPMA J; 2020 Sep; 11(3):419-467. PubMed ID: 32849927
[TBL] [Abstract][Full Text] [Related]
6. Elevated Hexokinase II Expression Confers Acquired Resistance to 4-Hydroxytamoxifen in Breast Cancer Cells.
Liu X; Miao W; Huang M; Li L; Dai X; Wang Y
Mol Cell Proteomics; 2019 Nov; 18(11):2273-2284. PubMed ID: 31519767
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen resistance in breast cancer.
Chang M
Biomol Ther (Seoul); 2012 May; 20(3):256-67. PubMed ID: 24130921
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells.
Okoh VO; Felty Q; Parkash J; Poppiti R; Roy D
PLoS One; 2013; 8(2):e54206. PubMed ID: 23437041
[TBL] [Abstract][Full Text] [Related]
9. Expression of integrin-linked kinase in lung squamous cell carcinoma and adenocarcinoma: correlation with E-cadherin expression, tumor microvessel density and clinical outcome.
Yu J; Shi R; Zhang D; Wang E; Qiu X
Virchows Arch; 2011 Jan; 458(1):99-107. PubMed ID: 21136077
[TBL] [Abstract][Full Text] [Related]
10. Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors.
Lombardero M; Vidal S; Hurta R; Román A; Kovacs K; Lloyd RV; Scheithauer BW
Pituitary; 2006; 9(2):137-43. PubMed ID: 16944045
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of VEGF-A mRNA by 17beta-estradiol in breast tumor cells lacking classical ER-alpha may be mediated through a variant form of ER-alpha.
Sengupta K; Banerjee S; Saxena NK; Jonathan NB; Campbell DR; Banerjee SK
Mol Cell Biochem; 2004 Jul; 262(1-2):215-24. PubMed ID: 15532726
[TBL] [Abstract][Full Text] [Related]
12. 2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells.
Banerjee SN; Sengupta K; Banerjee S; Saxena NK; Banerjee SK
Neoplasia; 2003; 5(5):417-26. PubMed ID: 14670179
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific regulation by estrogen of ezrin and ezrin/radixin/moesin-binding protein 50.
Smith PM; Cowan A; Milgram SL; White BA
Endocrine; 2003 Nov; 22(2):119-26. PubMed ID: 14665715
[TBL] [Abstract][Full Text] [Related]
14. 17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway.
Banerjee S; Saxena N; Sengupta K; Banerjee SK
Biochem Biophys Res Commun; 2003 Jan; 300(1):209-15. PubMed ID: 12480545
[TBL] [Abstract][Full Text] [Related]
15. Estradiol rapidly activates Akt via the ErbB2 signaling pathway.
Stoica GE; Franke TF; Wellstein A; Czubayko F; List HJ; Reiter R; Morgan E; Martin MB; Stoica A
Mol Endocrinol; 2003 May; 17(5):818-30. PubMed ID: 12554767
[TBL] [Abstract][Full Text] [Related]
16. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway.
Kazi AA; Koos RD
Endocrinology; 2007 May; 148(5):2363-74. PubMed ID: 17272396
[TBL] [Abstract][Full Text] [Related]
18. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
Gao N; Nester RA; Sarkar MA
Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
[TBL] [Abstract][Full Text] [Related]
19. Regulation of vascular endothelial growth factor expression by estrogens and progestins.
Hyder SM; Huang JC; Nawaz Z; Boettger-Tong H; Mäkelä S; Chiappetta C; Stancel GM
Environ Health Perspect; 2000 Oct; 108 Suppl 5():785-90. PubMed ID: 11035983
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
